Retatrutide (LY-3437943) – Triple Agonist Research Peptide
Retatrutide (LY-3437943) is a synthetic research peptide consisting of
39 amino acids with an exceptional purity of approximately
99.3%.
Due to its function as a triple receptor agonist targeting
GLP-1, GIP, and glucagon receptors, Retatrutide is highly relevant for
advanced research into metabolic regulation and energy balance.
This batch has been extensively analyzed by
Janoshik Independent Peptide Analytics and is supplied with a complete
Certificate of Analysis (COA), including HPLC, mass spectrometry,
and online verification.
The product is intended exclusively for controlled
biochemical and metabolic research in in-vitro environments.
Key specifications
| Specification | Value / description |
|---|---|
| Purity | ≈ 99.3% (HPLC tested – COA available) |
| Molecular formula / weight | C221H342N46O68 / 4,731.33 Da |
| Amino acid sequence | Fully documented in COA / test report |
| Analytical laboratory | Janoshik Independent Peptide Analytics |
| Test report |
View official Janoshik test report |
| Verification key | HNPIA5278PM1 |
| Task number | 88106 |
| Analytical methods | HPLC and MS |
| Form | Lyophilized powder |
| Storage conditions | Store refrigerated, protected from light and moisture |
Research relevance & advantages
- Triple agonist activity provides unique insight into glucose regulation and energy homeostasis.
- Highly relevant in preclinical research focused on metabolism, fat oxidation, and appetite mechanisms.
- Represents an advanced successor to dual-agonist research models through synergistic receptor interaction.
- Fully verifiable quality supported by COA and independent Janoshik testing.
